NEXGEN CR-FLEX FEMORAL COMPONENT
Report
- Report Number
- 1822565-2012-01544
- Event Type
- Injury
- Date Received
- July 20, 2012
- Date of Event
- July 11, 2011
- Report Date
- March 16, 2020
- Manufacturer
- ZIMMER, INC.
- Product Code
- JWH
- PMA / PMN Number
- K031061
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SC, US
- Reporter Occupation
- PHYSICIAN
Narratives
EVALUATION SUMMARY: NEITHER SURGICAL NOTES NOR X-RAYS WERE PROVIDED, THEREFORE FIT AND ORIENTATION COULD NOT BE EVALUATED. PT FACTORS THAT MAY AFFECT THE PERFORMANCE OF THE COMPONENTS SUCH AS BONE QUALITY, ACTIVITY LEVEL OR TYPE OF ACTIVITY (LOW IMPACT VS. HIGH IMPACT) ARE UNKNOWN. A DEFINITIVE ROOT CAUSE CANNOT BE DETERMINED WITH THE INFORMATION PROVIDED. REVIEW OF THE DEVICE HISTORY RECORDS DID NOT FIND ANY DEVIATIONS OR ANOMALIES. IT IS NOT SUSPECTED THAT THE PRODUCT CONTRIBUTION TO THE REPORTED PROBLEM. BASED ON THE INVESTIGATION, THE NEED FOR CORRECTIVE ACTION IS NOT INDICATED. SHOULD ADDITIONAL SUBSTANTIVE INFORMATION BE RECEIVED, THE COMPLAINT WILL BE REOPENED. ZIMMER, INC. CONSIDERS THE INVESTIGATION CLOSED.
THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY UPDATED AND ADDITIONAL INFORMATION. MEDICAL PRODUCTS: CR-FLEX POR FEM E-R; P/N: 00595201502, L/N: 61161887; NEXGEN TM TIB COMPONENT, SZ 6; P/N: 00595404702, L/N: 61068767; XLPE CR ART SURF CH56/GRN 17; P/N: 90595204017, L/N: 61023242; NEXGEN MIS TM FLEX SCREW; P/N: 00595409000, L/N: 61017079. COMPLAINT SAMPLE WAS EVALUATED AND THE REPORTED EVENT WAS CONFIRMED. VISUAL EXAMINATION OF THE RETURNED COMPONENTS (FEMORAL IMPLANT, ARTICULAR SURFACE) NOTED THAT THEY EXHIBIT SIGNS OF BEING IMPLANTED. THE BACKSIDE OF THE FEMORAL IMPLANT IS MOSTLY FREE OF BIOLOGICAL REMAINS WITH SOME FIBROUS/BONY REMAINS ANCHORED TO THE POROUS COATING ONLY IN FEW RANDOM LOCATIONS. THE BUFFED CONDYLAR SURFACES ARE WORN. ONLY THE LATERAL CONDYLAR SURFACE OF THE ARTICULAR SURFACE FEATURES A SMALL SCRATCH IN THE POSTERO-LATERAL REGION. DIMENSIONAL ANALYSIS OF THE FEMORAL IMPLANT PASSED WHERE MEASURED. PER THE INSTRUCTIONS FOR USE OF THE IMPLANTS, PAIN, AND LOOSENING OF THE PROSTHETIC KNEE COMPONENTS ARE KNOWN POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH THE TKA PROCEDURE. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. A DEFINITIVE ROOT CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.
IT WAS REPORTED THAT THE PT IS ALLEGING HARM CAUSED BY THE DEVICE, HOWEVER, THE NATURE OF THE HARM IS UNKNOWN AT THIS TIME.
IT WAS FURTHER REPORTED THAT THE PATIENT WAS REVISED APPROXIMATELY TWO YEARS POST-IMPLANTATION DUE TO ASEPTIC LOOSENING OF THE FEMORAL COMPONENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | NEXGEN CR-FLEX FEMORAL COMPONENT | JWH | ZIMMER, INC. | 61161887 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 56 YR | Hospitalization| O| R |